AEON Biopharma Appoints Dr. Chad K. Oh as Chief Medical Officer to Lead Clinical Development of ABP-450 Across Several Therapeutic Indications

NEXT STORY
BriaCell to Host Corporate and Clinical Update Conference Call Wednesday, June 16, 2021 at 4:30 p.m. ET
PREV STORY
Clover Health to Scale In-home Primary Care Program Through Direct Contracting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Athenex and the Center for Cell and Gene Therapy Announce Allowance of Our First U.S. Patent Claims Around CAR-NKT Cell Therapy

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces First Presentation of Preclinical Data Utilizing TransCon™ Technology in Oncology at SITC 2019

author_avatar
NASDAQ Market News

Dynavax Reports Fourth Quarter and Year End 2017 Financial Results

HEPLISAV-B Launched in the United States Phase 2 Data in Two Immuno-oncology Programs Planned ...

author_avatar
NASDAQ Market News